Abstract: A probe head includes a probe seat, and vertical probes each having a head portion including a head portion installation section with a first width, and a probe tip section including a probe tip contact part with a second width smaller than the first width and a probe tip gradually narrowing part which is located between the head portion installation section and the probe tip contact part, gradually narrows from the first width to the second width, and has a first length smaller than a second length of the probe tip contact part. The head portion installation section protrudes out of a lower surface of the probe seat for a length smaller than the sum of the first and second lengths. The vertical probe is great in current withstanding capability, structural strength and life time, and meets the requirement of probing tiny electrically conductive contacts.

Abstract: A method of manufacturing an electroluminescent device includes forming a first patterned structure in a first pixel through a first opening of a first sacrificial layer; removing the first sacrificial layer; forming a second patterned structure in a second pixel through a second opening of a second sacrificial layer; removing the second sacrificial layer; and removing a first patterned protecting layer from the first patterned structure and a second patterned protecting layer from the second patterned structure to respectively form a first patterned light-emitting layer and a second patterned light-emitting layer.

Abstract: A method of manufacturing an electroluminescent device includes providing a substrate including a first pixel and a second pixel configured to emit different colors; forming a first light-emitting layer and a first protecting layer over the substrate through a first opening of a first sacrificial layer; forming a second light-emitting layer and a second protecting layer over the substrate through a second opening of a second sacrificial layer; removing the first sacrificial layer together with the second sacrificial layer; and removing the first protecting layer from the first light-emitting layer, and the second protecting layer from the second light-emitting layer.

Abstract: A method of manufacturing an electroluminescent device includes forming a first patterned structure in a first pixel through a first opening of a first sacrificial layer; removing the first sacrificial layer; forming a second patterned structure in a second pixel through a second opening of a second sacrificial layer; removing the second sacrificial layer; and removing a first patterned protecting layer from the first patterned structure and a second patterned protecting layer from the second patterned structure to respectively form a first patterned light-emitting layer and a second patterned light-emitting layer.

Abstract: A method of manufacturing an electroluminescent device includes providing a substrate including a first pixel and a second pixel configured to emit different colors; forming a first light-emitting layer and a first protecting layer over the substrate through a first opening of a first sacrificial layer; forming a second light-emitting layer and a second protecting layer over the substrate through a second opening of a second sacrificial layer; removing the first sacrificial layer together with the second sacrificial layer; and removing the first protecting layer from the first light-emitting layer, and the second protecting layer from the second light-emitting layer.

Abstract: The present invention provides novel protein transfection kits comprising protein transfection compositions, wherein the protein transfection composition including a Zwitterionic buffer and optionally a minimal essential medium. Also provided are methods of transfecting cells with a protein using the protein transfection compositions disclosed herein to inhibit cancer cell growth and other purposes such as research.

Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.

Abstract: A backlight module is provided, and includes: a plurality of LED strings, each of which is formed from a plurality of LEDs connected in series and has an LED string current flowing through it, and a dimming controller which controls the duty cycle of a voltage pulse wave supplied to each of the LED strings, wherein the LED string current of each of the LED strings multiplied by the duty cycle of the voltage pulse wave for the same LED string equals a value, and the error between the values of the LED strings is within 6% of any of the values.

Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide.

Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.

Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.

Abstract: Disclosed herein are a composite nanoparticle and a process for preparing the same. The composite nanoparticle includes Rev peptides chemically bonded to gold. Also disclosed herein are a pharmaceutical composition including a plurality of the aforesaid composite nanoparticles, and a method of inhibiting tumor/cancer cells by virtue of the aforesaid composite nanoparticle.

Abstract: Disclosed herein is a method for the detection, preliminary screening or monitoring of a gynecological disease selected form ovarian cancers and endometriosis, in which STIP1 is used as a biomarker for the gynecological disease.

Abstract: Disclosed herein is a method for the detection, preliminary screening or monitoring of a gynecological disease selected form ovarian cancers and endometriosis, in which STIP1 is used as a biomarker for the gynecological disease.